ARCHIVES

Alimta Granted Approval As NSCLC Continuation Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

June 6, 2014

Other Contract Concepts Approved By DCE Board

March 10, 1989

Survey Commissioned By Cancer Control Program Finds Important RMP Effort Being Phased Out

July 19, 1974

Proposed Guidelines For Clinical Tests Of Oncologic Drugs

November 28, 1975

FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.

June 30, 2000

Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8

February 3, 1978